Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-08 5:01 pm Purchase | 2023-05-04 | 13D | KINNATE BIOPHARMA INC KNTE | ORBIMED ADVISORS LLC | 7,559,729 16.200% | 1,460,932 (+23.95%) | Filing History |
| 2023-05-05 11:14 am Unchanged | 2023-05-01 | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.100% | 0 (Unchanged) | Filing History |
| 2023-05-02 7:28 pm Purchase | 2023-04-28 | 13D | KINNATE BIOPHARMA INC KNTE | ORBIMED ADVISORS LLC | 6,098,797 13.100% | 1,405,168 (+29.94%) | Filing History |
| 2023-04-21 5:03 pm Sale | 2023-04-19 | 13D | TELA BIO INC TELA | ORBIMED ADVISORS LLC | 2,866,267 11.900% | -192,000 (-6.28%) | Filing History |
| 2023-04-11 7:10 pm Purchase | 2023-03-29 | 13D | APOLLOMICS INC. USD SHS APLM | ORBIMED ADVISORS LLC | 6,626 10.300% | 6,626 (New Position) | Filing History |
| 2023-04-07 4:38 pm Sale | 2023-04-05 | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 107,866 10.500% | -2,992 (-2.70%) | Filing History |
| 2023-03-31 4:48 pm Purchase | 2023-03-29 | 13D | GRACELL BIOTECHNOLOGIES INC SP GRCL | ORBIMED ADVISORS LLC | 7,583,576 11.200% | 1,612,904 (+27.01%) | Filing History |
| 2023-03-29 5:24 pm Unchanged | 2023-03-27 | 13D | TERNS PHARMACEUTICALS INC TERN | ORBIMED ADVISORS LLC | 7,619,135 13.400% | 0 (Unchanged) | Filing History |
| 2023-03-24 4:57 pm Unchanged | 2023-03-22 | 13D | CALCIMEDICA INC CALC | ORBIMED ADVISORS LLC | 297,380 5.400% | 0 (Unchanged) | Filing History |
| 2023-03-24 4:43 pm Sale | 2023-03-22 | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 0 0.000% | -1,504,436 (Position Closed) | Filing History |
| 2023-03-22 4:27 pm Purchase | 2023-03-20 | 13D | CALCIMEDICA INC CALC | ORBIMED ADVISORS LLC | 297,380 18.900% | 297,380 (New Position) | Filing History |
| 2023-03-14 4:19 pm Purchase | 2023-03-09 | 13D | THESEUS PHARMACEUTICALS INC CO THRX | ORBIMED ADVISORS LLC | 17,233,668 39.600% | 395,000 (+2.35%) | Filing History |
| 2023-02-28 5:09 pm Sale | 2023-02-16 | 13D | FUSION PHARMACEUTICALS INC FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.700% | -67,311 (-2.25%) | Filing History |
| 2023-02-28 4:00 pm Purchase | 2023-02-23 | 13D | ENLIVEN THERAPEUTICS INC ELVN | ORBIMED ADVISORS LLC | 8,949,339 21.800% | 6,416,937 (+253.39%) | Filing History |
| 2023-02-23 3:23 pm Purchase | 2023-02-17 | 13D | KINNATE BIOPHARMA INC KNTE | ORBIMED ADVISORS LLC | 4,693,629 10.600% | 1,295,700 (+38.13%) | Filing History |
| 2023-02-14 5:24 pm Purchase | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 344,288 8.200% | 283,076 (+462.45%) | Filing History |
| 2023-02-14 5:20 pm Sale | 2022-12-31 | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | ORBIMED ADVISORS LLC | 0 0.000% | -350,641 (Position Closed) | Filing History |
| 2023-02-14 5:16 pm Purchase | 2022-12-31 | 13G | VERASTEM, INC. VSTM | ORBIMED ADVISORS LLC | 1,375,270 7.900% | 1,375,270 (New Position) | Filing History |
| 2023-02-14 5:12 pm Purchase | 2022-12-31 | 13G | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 6,713,561 10.700% | 1,810,057 (+36.91%) | Filing History |
| 2023-02-14 5:07 pm Sale | 2022-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 0 0.000% | -5,456,780 (Position Closed) | Filing History |